The Impact of Nanomedicine Development on North-South Equity and Equal Opportunities in Healthcare

Michael G. Tyshenko

doi:10.2202/1941-6008.1118

Article

The Impact of Nanomedicine Development on North-South Equity and Equal Opportunities in Healthcare

Michael G. Tyshenko

Published/Copyright: December 17, 2009

Published by

Become an author with De Gruyter Brill

Author Information Explore this Subject

From the journal Studies in Ethics, Law, and Technology Volume 3 Issue 3

Nanomedicine applications are an extension of traditional pharmaceutical drug development that are targeting the most pressing health concerns through improvements to diagnostics, drug delivery systems, therapeutics, equipment, surgery and prosthetics. The benefits and risks to the individual have been extrapolated to include broader societal impacts of nanomedicine with concerns extending to inequitable distribution of benefits accruing to developed, or North countries, rather than developing, or South countries. Analysis reveals a great deal of overlap between the North and South's most serious health priorities which kill millions each year. A significant amount of nanomedicine research activity is also underway for the most pressing South country-specific health concerns. Nanomedicine development promises profound breakthroughs for both North and South countries; however, the existing inequities in pharmaceutical drug development, patenting, access and delivery remain significant barriers for South countries.

Keywords: nanomedicine; equity; drug development; South countries; North countries

Published Online: 2009-12-17

You are currently not able to access this content.

Articles in the same Issue

https://doi.org/10.2202/1941-6008.1118

Keywords for this article

nanomedicine; equity; drug development; South countries; North countries